Latest news
Heron Therapeutics misses Q2 earnings and reven... - PluangPluang · Mon, 10 Aug 2026 18:06:40 GMTHeron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 15:05:39 GMTdevelopment in the article - MinichartMinichart · Mon, 10 Aug 2026 12:43:00 GMTHeron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook - TradingViewTradingView · Mon, 10 Aug 2026 12:08:40 GMTHeron Therapeutics reports Q2 2026 revenue $37.7M, withdraws 2026 guidance after patent ruling - TradingViewTradingView · Mon, 10 Aug 2026 12:03:01 GMTHeron Therapeutics Announces Second Quarter 2026 Financial Results - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 12:00:00 GMT